POLE and colorectal carcinoma: In stage II/III tumors, only four of 59 (8%) PolE-mutated patients experienced recurrence after surgery (median duration of 4.7 years), compared to 130 of 689 patients (18.9%) with MSI-H CRC and 1074 of 3905 patients (27.5%) with MSS CRC.